Financial Statements

Kwality Pharmaceuticals Profit & Loss Statement

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 88.10 1.31 39.80 32.50
Op profit growth 103 21.70 32.10 76.70
EBIT growth 78.50 41.50 26 105
Net profit growth 82.10 82.90 35.10 116
Profitability ratios (%)        
OPM 11 10.20 8.48 8.98
EBIT margin 9.14 9.63 6.90 7.65
Net profit margin 5.78 5.97 3.31 3.42
RoCE 26.40 19.80 18.90 19
RoNW 7.07 5.49 4.11 3.55
RoA 4.18 3.07 2.27 2.12
Per share ratios ()        
EPS 14.40 7.91 4.26 6.32
Dividend per share -- -- -- 0.60
Cash EPS 8.34 3.74 1.51 1.65
Book value per share 58.90 44.30 28.70 49.30
Valuation ratios        
P/E 3.90 3.23 9.62 7.59
P/CEPS 6.72 6.83 27.10 29.10
P/B 0.95 0.58 1.43 0.97
EV/EBIDTA 3.07 3.36 5.41 6.57
Payout (%)        
Dividend payout -- -- -- 11
Tax payout (30) (25) (39) (42)
Liquidity ratios        
Debtor days 46 88.30 79.20 75.40
Inventory days 27.70 49.10 38.30 44.90
Creditor days (38) (66) (51) (46)
Leverage ratios        
Interest coverage (9) (5.40) (4.30) (4)
Net debt / equity 0.58 0.73 0.83 0.63
Net debt / op. profit 1.23 2.36 2.13 1.82
Cost breakup ()        
Material costs (63) (63) (74) (72)
Employee costs (6.10) (8.60) (4.10) (4.30)
Other costs (20) (19) (14) (14)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 262 139 137 98.30
yoy growth (%) 88.10 1.31 39.80 32.50
Raw materials (166) (87) (101) (71)
As % of sales 63.20 62.50 73.70 72.40
Employee costs (16) (12) (5.60) (4.20)
As % of sales 6.07 8.57 4.08 4.30
Other costs (52) (26) (19) (14)
As % of sales 19.70 18.70 13.80 14.30
Operating profit 28.80 14.20 11.70 8.82
OPM 11 10.20 8.48 8.98
Depreciation (6.50) (4.40) (3) (2.50)
Interest expense (2.70) (2.50) (2.20) (1.90)
Other income 1.59 3.66 0.80 1.21
Profit before tax 21.30 10.90 7.30 5.65
Taxes (6.40) (2.70) (2.90) (2.40)
Tax rate (30) (25) (39) (42)
Minorities and other 0.26 0.11 0.12 0.09
Adj. profit 15.10 8.32 4.55 3.36
Exceptional items -- -- -- --
Net profit 15.10 8.32 4.55 3.36
yoy growth (%) 82.10 82.90 35.10 116
NPM 5.78 5.97 3.31 3.42
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 21.30 10.90 7.30 5.65
Depreciation (6.50) (4.40) (3) (2.50)
Tax paid (6.40) (2.70) (2.90) (2.40)
Working capital 33 22.80 5.85 (5.90)
Other operating items -- -- -- --
Operating cashflow 41.40 26.60 7.29 (5.10)
Capital expenditure 62.40 39.80 6.25 (6.30)
Free cash flow 104 66.40 13.50 (11)
Equity raised 56.40 49.40 40.40 31.50
Investments 4.17 2.05 1.69 (1.70)
Debt financing/disposal 35.20 23.50 9.73 (4.60)
Dividends paid -- -- -- 0.31
Other items -- -- -- --
Net in cash 200 141 65.40 14.20
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 10.40 10.40 10.40 10.40
Preference capital -- -- -- --
Reserves 50.80 35.60 26.90 19.40
Net worth 61.20 46 37.30 29.80
Minority interest
Debt 41.20 35 28.70 26.50
Deferred tax liabilities (net) 0.16 0.12 0.21 0.40
Total liabilities 101 80.10 65.30 55.60
Fixed assets 59.40 42.70 29.10 20.40
Intangible assets
Investments 5.17 3.99 4.82 5.34
Deferred tax asset (net) 0.20 0.32 0.09 0.19
Net working capital 30.60 31.50 29.90 28.10
Inventories 17.40 22.40 11.30 15
Inventory Days 24.20 58.70 -- 39.90
Sundry debtors 35.70 30.30 38.40 37
Debtor days 49.70 79.50 -- 98.30
Other current assets 42.80 31.50 20.40 16.80
Sundry creditors (26) (23) (17) (22)
Creditor days 36.50 60.20 -- 58.80
Other current liabilities (39) (30) (23) (19)
Cash 5.81 1.54 1.40 1.61
Total assets 101 80.10 65.30 55.60
Switch to
Consolidated
Standalone


Report not showing data
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity